Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Hirsutism treatment should focus more on patient needs and quality of life.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

M30 is a promising treatment for preventing hair loss during chemotherapy.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

MVP treatment is effective and safe for recurrent breast cancer.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

The guideline recommends using specific drugs and surgery together for treating hidradenitis suppurativa effectively.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Current treatments for cicatricial alopecia can manage symptoms but don't stop hair loss or the disease.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.